98 GENES FOUND

? »

Limit search: Premium | Premium (Subcell) | Premium (Cell line)

« prev | Page of 2

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

HSD3B1Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
HSD3B2Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
HTR2A5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupledFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
ICAM1Intercellular adhesion molecule 1Cancer-related genes
Candidate cardiovascular disease genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IL2RAInterleukin 2 receptor, alphaCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
IL2RBInterleukin 2 receptor, betaCancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
IL2RGInterleukin 2 receptor, gammaCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
ITGA2BIntegrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)Cancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
ITGALIntegrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ITGAVIntegrin, alpha VCancer-related genes
CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
ITGB3Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
KCNA5Potassium voltage-gated channel, shaker-related subfamily, member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Group enriched
KCNB1Potassium voltage-gated channel, Shab-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNC1Potassium voltage-gated channel, Shaw-related subfamily, member 1FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNJ1Potassium inwardly-rectifying channel, subfamily J, member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNQ1Potassium voltage-gated channel, KQT-like subfamily, member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KITV-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homologCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Mixed
MAOAMonoamine oxidase ADisease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Mixed
MAOBMonoamine oxidase BEnzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Mixed
MGAMMaltase-glucoamylase (alpha-glucosidase)Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Group enriched
MMEMembrane metallo-endopeptidaseCancer-related genes
Candidate cardiovascular disease genes
CD markers
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
MS4A1Membrane-spanning 4-domains, subfamily A, member 1CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Group enriched
MS4A2Membrane-spanning 4-domains, subfamily A, member 2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Mixed
NPC1L1NPC1-like 1FDA approved drug targets
Predicted membrane proteins
Group enriched
OPRM1Opioid receptor, mu 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
P2RY12Purinergic receptor P2Y, G-protein coupled, 12Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
PDGFRBPlatelet-derived growth factor receptor, beta polypeptideCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
PROS1Protein S (alpha)Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
PSMD1Proteasome (prosome, macropain) 26S subunit, non-ATPase, 1FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
RYR1Ryanodine receptor 1 (skeletal)Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enriched
SCN2ASodium channel, voltage-gated, type II, alpha subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
SISucrase-isomaltase (alpha-glucosidase)Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Group enriched
SIGMAR1Sigma non-opioid intracellular receptor 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
SLC12A1Solute carrier family 12 (sodium/potassium/chloride transporter), member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC12A3Solute carrier family 12 (sodium/chloride transporter), member 3Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enriched
SLC12A5Solute carrier family 12 (potassium/chloride transporter), member 5FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC22A8Solute carrier family 22 (organic anion transporter), member 8FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC5A2Solute carrier family 5 (sodium/glucose cotransporter), member 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
SLC6A1Solute carrier family 6 (neurotransmitter transporter), member 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Group enriched
SOAT1Sterol O-acyltransferase 1Enzymes
FDA approved drug targets
Predicted membrane proteins
Tissue enriched
SV2ASynaptic vesicle glycoprotein 2AFDA approved drug targets
Predicted membrane proteins
Tissue enriched
SYT2Synaptotagmin IIFDA approved drug targets
Predicted membrane proteins
Tissue enhanced
TBXAS1Thromboxane A synthase 1 (platelet)Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Mixed
TLR7Toll-like receptor 7FDA approved drug targets
Predicted membrane proteins
Mixed
TNFRSF8Tumor necrosis factor receptor superfamily, member 8Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Mixed
TNFSF11Tumor necrosis factor (ligand) superfamily, member 11Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
TPOThyroid peroxidaseDisease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
TYRTyrosinaseDisease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Tissue enriched

« prev | Page of 2